ACNNF Stock Overview – The Average Joe
Business Economy Tech Subscribe About Us
PNK:ACNNF

Loading...

Market cap

$Loading...

Sector

Loading...

Dividend Yield

Loading...

52-week range

Loading... Loading...

Expected earnings date

September 25, 2024

Description

Loading...

Price Performance

1M 6M 1Y 5Y 10Y
$ACNNF N/A N/A N/A N/A N/A
S&P500 N/A N/A N/A N/A N/A

Valuation

P/E Ratio (TTM) P/S Ratio (TTM)
AusCann Group Holdings Ltd Loading... Loading...
Sector Name Loading... N/A

Related

AXRXAmexdrug Corporation5.0%
ANTCFAion Therapeutic Inc.189.5%
APNHFAspen Pharmacare Holdings Limited30.4%
ATHJFAntisense Therapeutics Limited150.0%
ABTIAlterola Biotech, Inc.-10.8%

Analyst Ratings

Buy Loading...
Hold Loading...
Sell Loading...

Financial Overview

FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023
Revenue0M0M0M0M0M1M0M2M2M2M
Growth Rate-0.0%0.0%0.0%0.0%1,146.2%-99.5%51,273.7%-8.0%2.4%
EBITDA-1M0M-1M-14M-8M-5M-7M-9M16M-12M
EBITDA Margin0.0%0.0%0.0%0.0%-14,701.5%-759.5%-232,173.0%-545.2%1,088.9%-753.0%
Net Income-1M0M-1M-14M-8M-8M-7M-9M-26M-11M
NI Margin0.0%0.0%0.0%0.0%-14,249.7%-1,140.6%-220,855.6%-525.0%-1,740.8%-697.3%